FONT-SIZE Plus   Neg

ResMed: German Court Concludes Fisher Infringes Two ResMed European Patents

ResMed (RMD) announced updates in ongoing global patent infringement litigation with Fisher & Paykel. The company said, in Germany, the court concluded that Fisher & Paykel's Simplus, Eson and Eson 2 each infringe two ResMed European patents. The court stayed the infringement proceedings to permit ResMed to defend the validity of its patents in the European Patent Office.

In the United Kingdom, ResMed is proceeding to trial in defense of one of three UK ResMed patents that Fisher & Paykel has challenged, while agreeing to revoke the other two UK patents.

The company said, in Australia, after ResMed presented its evidence defending a key ResMed mask patent, Fisher & Paykel immediately withdrew its validity challenge to the patent. In New Zealand, ResMed's case against Fisher & Paykel for patent infringement is moving forward to a trial in late 2018.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Dutch semiconductor equipment maker ASML Holding NV reported Wednesday higher profit in its third quarter as sales were boosted mainly with strong demand for DUV Systems. Meanwhile, margin declined. Looking ahead, the company projects sequentially lower sales in its fourth quarter. For fiscal 2017, the company maintained forecast for higher sales. Leaders of the Senate Health Committee revealed Tuesday they have reached an agreement on legislation to provide short-term stability to Obamacare. Committee Chairman Lamar Alexander, R-Tenn., and ranking member Patty Murray, D-Wash., announced the bipartisan agreement. Activist investor Rudolf Bohli is reportedly targeting Switzerland's second largest bank Credit Suisse. Bloomberg reported that Bohli has 0.2 percent stake in Credit Suisse that comes around 100 million francs or around $102 million.
comments powered by Disqus
Follow RTT